23 March 2020
: Case report
Necessity of Utilizing Physiological Glucocorticoids for Managing Familial Mediterranean Fever
Unusual clinical course, Unusual or unexpected effect of treatment
Kenji Ashida12ABCDEF*, Eriko Terada1ABCDEF, Ayako Nagayama2BCDEF, Shohei Sakamoto1BCDEF, Nao Hasuzawa12BCDEF, Masatoshi Nomura12ABCDEFDOI: 10.12659/AJCR.920983
Am J Case Rep 2020; 21:e920983
Abstract
BACKGROUND: Familial Mediterranean fever is an auto-inflammatory disease caused by pyrin mutations. Glucocorticoids inhibit the production and secretion of inflammatory cytokines, including IL-6 and IL-1β, from inflammatory cells and suppress the activation of nuclear factor-κB in the nucleus. However, the functions of physiological glucocorticoids in the disease remain unknown.
CASE REPORT: We report the case of a Japanese man with familial Mediterranean fever complicated by isolated adrenocorticotropic hormone deficiency. Patient non-compliance with hydrocortisone replacement therapy led to a series of pericarditis and fever episodes. Subsequently, the regular administration of colchicine alone could not prevent auto-inflammation. The clinical course of treatment suggested that the absence of physiological levels of glucocorticoids is crucial for familial Mediterranean fever attacks. Because familial Mediterranean fever is a pyrin abnormality-induced auto-inflammatory disease that subsequently activates cytokines via the nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3 inflammasomes and the absence of glucocorticoids can exacerbate the severity of the auto-inflammatory disease.
CONCLUSIONS: Physiological glucocorticoid levels appear to be essential for the regulation of inflammasome activation via IL-6-negative regulation. However, pharmacological levels of glucocorticoids are not currently used for the prevention of familial Mediterranean fever attacks. Physicians should be aware of adrenal insufficiency as a possible disorder when they encounter cases of refractory familial Mediterranean fever.
Keywords: adrenal insufficiency, Colchicine, Familial Mediterranean Fever, Glucocorticoids, Cytokines, Hydrocortisone, Inflammasomes
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946560
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946727
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946839
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946674
Most Viewed Current Articles
21 Jun 2024 : Case report
96,182
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,159
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,026
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,365
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030